News & Blog

Latest from the Blog

  1. March 22, 2016

    Translating Brain Tumor Science Into Survival

    A version of the following article appeared originally in a special insert/section of USA TODAY today on 3/18/2016 called “Brain Health,” produced by Mediaplanet USA, as part of its “Future of Personal Health” campaign. In early 2016, the American Cancer Society released its annual “Cancer Statistics” report. The ensuing headlines in numerous media outlets broadcast the […]

    Read more | 
  2. March 18, 2016

    Moving The Field Toward More Patient-Focused Drug Development

    23982169463_252ae8b95f_o

    Together with our partners in the Jumpstarting Brain Tumor Drug Development Coalition – Accelerate Brain Cancer Cure (ABC2), Musella Foundation for Brain Tumor Research and Education, and the Society for Neuro-Oncology – NBTS has been advocating for the brain tumor research field to take patients’ quality of life into great account during clinical trials. As […]

    Read more | 
  3. March 14, 2016

    So You Heard About Rintega? Here’s What’s Next for Brain Tumor Drug Development

    STK_AnalyzingBrainScan

    Last week, news broke that a promising clinical trial of a new type of treatment for a subset of glioblastoma (GBM) patients – an immunotherapeutic vaccine made by Celldex Therapeutics called RINTEGA (rindopepimut) – was discontinued because patients receiving the investigational therapy were not doing better than patients in the control arm. As we said in our statement regarding […]

    Read more | 
Share